Y-27632 dihydrochloride

Archives

  • 2025-10
  • 2025-09
  • 2025-08
  • 2025-07
  • 2025-06
  • 2025-05
  • 2025-04
  • Harnessing Multi-Targeted RTK Inhibition: Mechanistic and...

    2025-10-21

    This thought-leadership article examines the evolving landscape of anti-angiogenic and multi-targeted receptor tyrosine kinase (RTK) inhibitor research, with a special focus on Sunitinib. We integrate mechanistic insights with experimental evidence—including new findings on ATRX-deficient gliomas—to guide translational researchers seeking to optimize cancer therapy strategies. Moving beyond standard product pages, we contextualize Sunitinib's capabilities, highlight competitive and clinical implications, and provide a forward-looking perspective on biomarker-driven translational studies.

  • Feprazone (Standard)

    2025-09-19

  • TCID

    2025-09-19

  • Prosapogenin CP6

    2025-09-18

  • MBX-2982

    2025-09-18

  • Anti-KAAG1 Antibody (ADCT-901)

    2025-09-17

  • Anti-PFKL Rabbit Monoclonal Antibody

    2025-09-16

  • Thimerosal

    2025-09-16

  • Tasisulam

    2025-09-15

  • Elenestinib

    2025-09-15

  • DiscoveryProbe鈩_Anti-Virus Compound Library

    2025-09-13

  • Anti-Phospho-MCM2 (Ser41) Rabbit Monoclo

    2025-09-13

  • MRT67307 HCl

    2025-09-11

  • Anti-CEACAM1CD66a Antibody (CM-24)

    2025-09-10

  • Muraglitazar

    2025-09-10

188 records 1/13 page Next 12345 下5页 Last page